Innoviva Inc. | Mutual Funds
Mutual Funds that own Innoviva Inc.
iShares Core S&P Small Cap ETF
3,849,373
3.79%
1,089
0.12%
09/06/2018
Fidelity Small Cap Discovery Fund
3,000,000
2.96%
-2,642,418
0.92%
04/30/2018
Fidelity Small Cap Value Fund
2,130,914
2.1%
-640,139
0.94%
04/30/2018
Fidelity Series Small Cap Discovery Fund
1,837,900
1.81%
-282,739
1.47%
04/30/2018
Vanguard Total Stock Market Index Fund
1,743,922
1.72%
2,208
0%
07/31/2018
Vanguard Small Cap Index Fund
1,662,409
1.64%
28,806
0.03%
07/31/2018
iShares Russell 2000 ETF
1,442,806
1.42%
-771
0.04%
09/06/2018
First Eagle Fund of America
1,364,550
1.34%
76,400
1.01%
04/30/2018
iShares S&P Small Cap 600 Growth ETF
1,181,576
1.15%
1,695
0.24%
09/06/2018
iShares Nasdaq Biotechnology ETF
1,176,728
1.15%
-15,393
0.17%
09/06/2018
| Address |
2000 Sierra Point Parkway
Brisbane California 94005
United States
|
|
Employees
|
- |
| Website |
http://www.inva.com |
| Updated |
07/08/2019 |
| Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. |
